. . . . "18"^^ . . "Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer"@nl . . . . "2015-02-01T00:00:00Z"^^ . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . . "Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer"@nl . . . . . "NCT00265850" . . . . . . . . . . . . "Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer"@en . . . . . . . . "A Phase III Trial of Irinotecan / 5-FU / Leucovorin or Oxaliplatin / 5-FU/ Leucovorin With Bevacizumab, or Cetuximab (C225), or With the Combination of Bevacizumab and Cetuximab for Patients With Untreated Metastatic Adenocarcinoma of the Colon or Rectum"@en . . . . . . . . . . . . . . . . . . . . . . . "Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer"@en . . . . . . . . . . "ensayu cl\u00EDnicu"@ast . . . . . . . . . . . . . . . . . . . . . . . . . "Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer"@en . . . . . . . . . . . . . . . . "2334"^^ . . . . . . . . . "clinical trial"@en . . . . . . . . . . . . . . . . . . "2005-11-01T00:00:00Z"^^ . . . . . . . "Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer"@nl . . "klinisch onderzoek"@nl . . . . . . . . . . . . . .